B. Riley Wealth Advisors Inc. Has $8.07 Million Stock Holdings in Stryker Co. (NYSE:SYK)

B. Riley Wealth Advisors Inc. reduced its stake in Stryker Co. (NYSE:SYK - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,366 shares of the medical technology company's stock after selling 1,115 shares during the period. B. Riley Wealth Advisors Inc.'s holdings in Stryker were worth $8,072,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. J. W. Coons Advisors LLC raised its position in Stryker by 0.7% in the fourth quarter. J. W. Coons Advisors LLC now owns 3,653 shares of the medical technology company's stock worth $1,315,000 after acquiring an additional 26 shares in the last quarter. Mascoma Wealth Management LLC grew its stake in shares of Stryker by 22.7% in the 4th quarter. Mascoma Wealth Management LLC now owns 146 shares of the medical technology company's stock worth $53,000 after purchasing an additional 27 shares during the last quarter. Opal Wealth Advisors LLC raised its holdings in shares of Stryker by 1.6% in the 4th quarter. Opal Wealth Advisors LLC now owns 1,816 shares of the medical technology company's stock worth $654,000 after purchasing an additional 28 shares in the last quarter. Lindbrook Capital LLC lifted its stake in Stryker by 2.0% during the fourth quarter. Lindbrook Capital LLC now owns 1,407 shares of the medical technology company's stock valued at $507,000 after purchasing an additional 28 shares during the last quarter. Finally, JFS Wealth Advisors LLC lifted its stake in Stryker by 4.4% during the fourth quarter. JFS Wealth Advisors LLC now owns 687 shares of the medical technology company's stock valued at $247,000 after purchasing an additional 29 shares during the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the transaction, the director now directly owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 5.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on SYK. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Roth Mkm boosted their target price on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research report on Friday, May 2nd. BTIG Research set a $403.00 price target on Stryker and gave the company a "buy" rating in a research report on Monday, April 14th. Canaccord Genuity Group lifted their price target on Stryker from $420.00 to $435.00 and gave the stock a "buy" rating in a research note on Wednesday, January 29th. Finally, Stifel Nicolaus upped their price objective on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Stryker currently has an average rating of "Moderate Buy" and an average price target of $427.30.

Stryker Stock Down 0.9%

Shares of NYSE:SYK traded down $3.53 during trading on Wednesday, reaching $380.25. 1,158,176 shares of the company traded hands, compared to its average volume of 1,344,556. The firm has a fifty day simple moving average of $368.24 and a 200 day simple moving average of $376.20. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. Stryker Co. has a 1-year low of $314.93 and a 1-year high of $406.19. The firm has a market cap of $145.14 billion, a P/E ratio of 49.00, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The firm had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter last year, the firm earned $2.50 earnings per share. The business's revenue for the quarter was up 11.9% on a year-over-year basis. Analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be paid a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.88%. Stryker's payout ratio is 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.